Ameri Pietro, Canepa Marco, Fabbi Patrizia, Leoncini Giovanna, Milaneschi Yuri, Mussap Michele, AlGhatrif Majd, Balbi Manrico, Viazzi Francesca, Murialdo Giovanni, Pontremoli Roberto, Brunelli Claudio, Ferrucci Luigi
Department of Internal Medicine, AOU-IRCCS San Martino-IST, University of Genova, Genova, Italy.
Department of Internal Medicine, AOU-IRCCS San Martino-IST, University of Genova, Genova, Italy; Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD, USA.
Atherosclerosis. 2014 Oct;236(2):418-25. doi: 10.1016/j.atherosclerosis.2014.08.022. Epub 2014 Aug 12.
Experimental evidence indicates that circulating insulin-like growth factor-1 (IGF-1) counteracts vascular aging and atherosclerosis, for which increased carotid artery intima-media thickness (IMT) is a marker. Yet, IGF-1 concentrations have been inconsistently associated with carotid IMT in epidemiological studies. Since vitamin D is also implicated in vascular protection and affects IGF-1 biology, we hypothesized that it would influence the effect of IGF-1 on IMT.
The relationship between carotid IMT and fasting serum IGF-1 was examined across strata of 25-hydroxyvitamin D [25(OH)D] in 472 participants in the Baltimore Longitudinal Study of Aging (BLSA) with well-controlled blood pressure and in 165 treatment-naive patients with essential hypertension from the Microalbuminuria: A Genoa Investigation on Complications (MAGIC) study. Moreover, the interplay between vitamin D and IGF-1 was preliminarily explored in EA.hy926 endothelial cells.
After adjusting for age, sex, BMI, renal function, smoking, systolic blood pressure, LDL-cholesterol, glycemia, antihypertensive or lipid-lowering therapy, season, parathyroid hormone, and vitamin D supplementation, IGF-1 was significantly and negatively associated with carotid IMT only within the lowest 25(OH)D quartile (range 6.8-26 ng/mL) of the BLSA (β -0.095, p = 0.03). Similarly, a significant negative correlation between IGF-1 and carotid IMT was found after full adjustment only in MAGIC patients with 25(OH)D concentrations below either the deficiency cut-off of 20 ng/mL (β -0.214, p = 0.02) or 26 ng/mL (β -0.174, p = 0.03). Vitamin D dose-dependently decreased hydrogen peroxide-induced endothelial cell oxidative stress and apoptosis, which were further inhibited by IGF in the presence of low, but not high vitamin D concentration.
Circulating IGF-1 is vasoprotective primarily when vitamin D levels are low. Future studies should address the mechanisms of vitamin D/IGF-1 interaction.
实验证据表明,循环胰岛素样生长因子-1(IGF-1)可对抗血管衰老和动脉粥样硬化,而颈动脉内膜中层厚度(IMT)增加是其一个标志物。然而,在流行病学研究中,IGF-1浓度与颈动脉IMT之间的关联并不一致。由于维生素D也与血管保护有关且影响IGF-1生物学特性,我们推测它会影响IGF-1对IMT的作用。
在巴尔的摩纵向衰老研究(BLSA)中472名血压控制良好的参与者以及来自微量白蛋白尿:热那亚并发症调查(MAGIC)研究的165名未经治疗的原发性高血压患者中,根据25-羟基维生素D[25(OH)D]分层研究颈动脉IMT与空腹血清IGF-1之间的关系。此外,在EA.hy926内皮细胞中初步探究了维生素D与IGF-1之间的相互作用。
在调整年龄、性别、体重指数、肾功能、吸烟、收缩压、低密度脂蛋白胆固醇、血糖、降压或降脂治疗、季节、甲状旁腺激素和维生素D补充剂后,仅在BLSA中最低的25(OH)D四分位数(范围6.8 - 26 ng/mL)内,IGF-1与颈动脉IMT显著负相关(β -0.095,p = 0.03)。同样,仅在25(OH)D浓度低于20 ng/mL(β -0.214,p = 0.02)或26 ng/mL(β -0.174,p = 0.03)的缺乏临界值的MAGIC患者中,经过全面调整后发现IGF-1与颈动脉IMT之间存在显著负相关。维生素D剂量依赖性地降低过氧化氢诱导的内皮细胞氧化应激和细胞凋亡,在低维生素D浓度而非高维生素D浓度存在时,IGF可进一步抑制上述情况。
主要在维生素D水平较低时,循环IGF-1具有血管保护作用。未来的研究应探讨维生素D/IGF-1相互作用的机制。